Juan Pablo (JP) Arab, MD
@juanpabloarab
Transplant Hepatologist & Clinical Researcher at @VCU_Liver. @FacMedicinaUC & @MayoClinic alumni. Love photography. Interests: #ALD #MASLD #Transplant. = mine
Alcohol-associated liver disease is one of the top threats to young adults. But it’s not the only one. MASLD. Viral hepatitis. Inflammation. Drug-induced damage. It’s time we stop pretending liver disease only looks one way. #MindYourLiver #ALD #LiverHealth #YoungAdults
Liver disease is silent. You might feel fine while damage builds. Don’t wait for symptoms. Protect your liver early. Mind Your Liver. It Needs You.™ #LiverAwareness #SilentButSerious #GenZHealth #LiverHealth #PreventionMatters #LiverDisease #MindYourLiver
Grateful to share that our paper was published in the @amjtransplant ! - CHD patients made up 42% of simultaneous heart- liver transplant (SHLT) - CHD recipients had 2x higher mortality risk - MP use is rising but outcomes remain suboptimal doi.org/10.1016/j.ajt.…
First IRB-approved before my start date at @VCU_Liver! Happy and grateful to hit the ground running at this amazing institution! 🙏 @juanpabloarab
Os invito a que os registréis ON-LINE al curso de actualización en #MASLD 19-20 Sept. Charlas disponibles durante un mes después del evento, así que la diferencia horaria no es problema! Y el precio es de solo $100, que para los pedazo de ponentes que tenemos es un regalo! Link👇
🤖🧠 An AI model accurately predicted inpatient death on day 1 of admission in patients with #cirrhosis. Developed by @JasmohanBajaj and colleagues @VCU, and published in @AGA_Gastro — it may help guide timely, individualized decisions. #LiverHealth bit.ly/3H3elu1
Recent expert commentary and the flagship event of the Global Think-Tank signal a long-overdue policy reckoning for chronic liver disease sldthinktank.com/policy_and_ins… #LiverTwitter #SLDthinktank @AASLDtweets @IntDiabetesFed @EASLEUAffairs @ncdalliance @WorldObesity @FattyLiverA
📣#MetALD: An Emerging Diagnosis Changing #ALD Care Pre- & Post-Transplant, featuring, leading expert, Dr. Juan Pablo Arab, 07/24, 8pm ET on Zoom. Share with patients! To receive an invite, join our no-cost community! bit.ly/3IFhLnm #LiverTwitter #Cirrhosis #FattyLiver
📣#MetALD: An Emerging Diagnosis Changing #ALD Care Pre- & Post-#Transplant. Featuring, leading expert, Dr. Juan Pablo Arab, 07/24, 8pm ET on Zoom. Send to patients! Receive an invite-join our no-cost community! bit.ly/4o1XmJq #LiverTwitter #Cirrhosis #AUD #LiverHealth
If you're looking for a world-renowned GI fellowship program, listen/watch @ArunJSanyalVCU discuss the VCU program: No. 9 worldwide, No. 4 in the U.S. and No. 1 in the South. See what we're about. bit.ly/4lWbZfh
Let’s build a healthier future—one liver at a time 💚 @IntMedatIowa @uiowa @_ILTS_ @ebtapper @rabataller @doctorbenlloch @kymwatt @juanpabloarab @felipeisidro13 @AnuSharma1025 @NaziaSelzner @MarkusSelzner @DeMadaria @Bealoquebea @ConradoFernnde1 #livertwitter
👇🏼@juanpabloarab @docMPK @giri_gutnliver @karanbjmc93
A new study should shift clinical practice for managing severe alcohol-associated hepatitis, writes Dr. Daniel Dressler. jwat.ch/4iHsM3G #hepatitis #MedTwitter @DresslerDD
LAF Supporters! Since our May 30 launch, the support has been unreal. Thank you for signing up, sharing stories, and joining our journey. We see you and appreciate you. 💜 Mind Your Liver. It Needs You.™ #MindYourLiver #LiverAwareness #LiverHealth #LiverDisease #ALD #Cirrhosis
AGILE, FAST, MEFIB, MASEF 🧪 Important review by my colleague @JTGrady02 and Prof. @RichSterlingMD looking at novel non-invasive tests for MASLD! @VCU_Liver @AASLDtweets @AmerGastroAssn @AmCollegeGastro
The FIB-4 and Fibroscan are the backbone of noninvasive fibrosis assessment in MASLD, but they're far from perfect! Here, we review novel noninvasive tests and how you can incorporate them into daily practice. #livertwitter @RichSterlingMD @VCU_Liver cghjournal.org/article/S1542-…
Welcome, @BlaneyMD!
I am very excited to announce that I will be joining @VCU_Liver following my graduation from Transplant Hepatology fellowship. As someone who loves caring for patients with liver disease, teaching, and researching the best organ ever, I cannot think of a better place to be! 🎉🤩
Full-circle moment: Our founder, Vanessa Wojtala returned to Francis Family Liver Clinic—not as a patient, but as a founder. Delivered the first Mind Your Liver Mag™. Thank you @LizLeeNP #MindYourLiver #LiverAwareness #ThisIsLAF
Honoured to be in this 🇨🇦 work in @AmJGastro w/ @mayurbrahmania @juanpabloarab and colleagues - Distance from LTx center 🚫 affect post-listing 🪦 or organ receipt. BUT, hospital🛌 and ER🏥 utilization ⬆️ in farther patients PRE-listing. #Livertwitter journals.lww.com/ajg/abstract/9…
✅ 7 years of Medical Training Thank you to my patients for trusting me and allowing me care for and learn from you Thank you to my co-trainees and faculty for the many lessons and being by my side Thank you to my husband and son (now 7!) for loving me (and sharing most of me)
VCU so lucky to land Dr Blaney Congratulations to everyone. How is VCU landing all these awesome people? Is it the force? Or … the dark side????
I am very excited to announce that I will be joining @VCU_Liver following my graduation from Transplant Hepatology fellowship. As someone who loves caring for patients with liver disease, teaching, and researching the best organ ever, I cannot think of a better place to be! 🎉🤩
Happy to share this RCT from @LiverGALAXY in people with ALD Out today in @NaturePortfolio rdcu.be/eujFT The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial